Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study - PubMed (original) (raw)
Apostolia-Maria Tsimberidou
Research Funding: EMD Serono (Inst), Baxter (Inst), Foundation Medicine (Inst), Onyx Pharmaceuticals (Inst), Bayer (Inst), Boston Biomedical (Inst), Placon Therapeutics (Inst)
David S. Hong
Stock and Other Ownership Interests: MolecularMatch, Oncorena
Honoraria: Adaptimmune, Baxter, Merrimack Pharmaceuticals, Bayer
Consulting or Advisory Role: Baxter, Bayer
Research Funding: Novartis, Genentech, Eisai, AstraZeneca, Pfizer, miRNA Therapeutics, Amgen, Daiichi Sankyo, Merck, Mirati Therapeutics, Eli Lilly
Travel, Accommodations, Expenses: Loxo, miRNA Therapeutics
Other Relationship: Oncorena
Yang Ye
No relationship to disclose
Carrie Cartwright
No relationship to disclose
Jennifer J. Wheler
No relationship to disclose
Gerald S. Falchook
Employment: Sarah Cannon Research Institute, HealthONE
Research Funding: GlaxoSmithKline, Millennium Pharmaceuticals, EMD Serono, Celgene, MedImmune, Genmab, Vegenics, Novartis, AstraZeneca, Incyte, ARMO BioSciences, Kolltan Pharmaceuticals, 3-V Biosciences, AbbVie, Aileron Therapeutics, DelMar Pharmaceuticals, eFFECTOR Therapeutics, Strategia Therapeutics, FujiFilm, Hutchison MediPharma, Regeneron, Biothera, Curegenics, Curis, Eli Lilly, Jounce Therapeutics, OncoMed, Precision Oncology, Syndax, Taiho Pharmaceutical, Tesaro
Patents, Royalties, Other Intellectual Property: Handbook of Targeted Cancer Therapy: Millennium
Travel, Accommodations, Expenses: Millennium Pharmaceuticals, Sarah Cannon Research Institute, EMD Serono, Bristol-Myers Squibb
Aung Naing
Consulting or Advisory Role: Novartis, CytomX Therapeutics
Research Funding: National Cancer Institute, EMD Serono, MedImmune, Healios, Atterocor, Amplimmune, ARMO BioSciences, Karyopharm Therapeutics, Incyte, Novartis, Regeneron, Baxter
Travel, Accommodations, Expenses: ARMO BioSciences
Siqing Fu
No relationship to disclose
Sarina Piha-Paul
Consulting or Advisory Role: Genentech
Research Funding: GlaxoSmithKline, XuanZhu, Puma Biotechnology, Novartis, Merck Sharp & Dohme, Curis, Principa Biopharma, Biomarin, Helix BioPharma, Bayer, AbbVie, Incyte, Five Prime Therapeutics, Cerulean Pharma, MedImmune, Medivation
Filip Janku
Stock and Other Ownership Interests: Trovagene
Consulting or Advisory Role: Deciphera, Trovagene, Novartis, Sequenom, Foundation Medicine, Guardant Health
Research Funding: Biocartis, Trovagene, Novartis, BioMed Valley Discoveries, Foundation Medicine, Roche, Agios, Astellas Pharma, Deciphera, Symphogen, Plexxikon, Piqur, FujiFilm
Other Relationship: Bio-Rad
Funda Meric-Bernstam
Honoraria: Dialecta
Consulting or Advisory Role: Genentech, Inflection Biosciences, Pieris Pharmaceuticals, Clearlight Diagnostics, Darwin Health
Research Funding: Novartis, AstraZeneca, Taiho Pharmaceutical, Genentech, Calithera Biosciences, Debiopharm Group, Bayer, Aileron Therapeutics, Puma Biotechnology, Verastem, CytomX Therapeutics, Jounce Therapeutics, Zymeworks, Effective Pharmaceuticals, Curis, Patrick Hwu
Stock and Other Ownership Interests: Lion Biotechnologies, Immatics
Consulting or Advisory Role: Lion Biotechnologies
Research Funding: Genentech
Patrick Hwu
Stock and Other Ownership Interests: Lion Biotechnolgies, Immatics
Consulting or Advisory Role: Lion Biotechnolgies
Research Funding: Genentech (Inst)
Bryan Kee
Stock and Other Ownership Interests: Medtronic
Merrill S. Kies
No relationship to disclose
Russell Broaddus
No relationship to disclose
John Mendelsohn
Leadership: Merrimack Pharmaceuticals
Stock and Other Ownership Interests: Merrimack Pharmaceuticals
Patents, Royalties, Other Intellectual Property: Royalty payments from University of California San Diego
Travel, Accommodations, Expenses: Merck
Kenneth R. Hess
Travel, Accommodations, Expenses: Angiochem
Razelle Kurzrock
Leadership: CureMatch
Stock and Other Ownership Interests: Actuate Therapeutics, CureMatch
Honoraria: XBiotech, Mayo Clinic Cancer Center, Kaiser Permanente, Health Advances, Wiley, Scripps Translational Research Institute, Defined Health, Roche
Consulting or Advisory Role: Sequenom, Actuate Therapeutics, XBiotech
Research Funding: EMD Serono (Inst), Genentech (Inst), Foundation Medicine (Inst), Pfizer (Inst), Guardant Health (Inst), Sequenom (Inst)
Patents, Royalties, Other Intellectual Property: No relationship to disclose
Travel, Accommodations, Expenses: EMD Serono, Gate-way Research Advisory Committee, Guardant Health, Global Source Ventures, Meyers Consulting, Genentech, Sylvester Cancer Center, CureMatch, Lynx Group, Mayo Clinic Cancer Center, Kaiser Permanente, Cedars-Sinai, MedImmune